Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Glaxo to Hire Hundreds in China as Reforms Widen Drug Access
Bloomberg
Monday, March 5, 2012 - 11:41am
tags:
China, drug reps, GSK
In Spite Of Dendreon's Woes, Other Players In The Sector Are Starting To Roll
Seeking Alpha
Monday, March 5, 2012 - 11:13am
tags:
Dendreon, Provenge, prostate cancer, Celldex, Agenus, Cel-Sci, ImmunoCellular
Exelixis announces initiation of trial combining cabozantinib, abiraterone
Yahoo/Fly on the Wall
Monday, March 5, 2012 - 11:12am
tags:
Exelixis, cabozantinib, abiraterone, prostate cancer
Seattle Genetics: A Cancer Niche Too Small
TheStreet.com
Monday, March 5, 2012 - 11:11am
tags:
Seattle Genetics, Adcetris, systemic anaplastic large cell lymphoma, Hodgkin's lymphoma
Threshold Scores Big With Pancreatic Cancer Data
Seeking Alpha
Monday, March 5, 2012 - 11:08am
tags:
pancreatic cancer, Threshold Pharmaceuticals, TH-302, Amgen, Array Biopharma, Micromet, Merck, Pharmacyclics
Lundbeck Anti-Binge Drinking Drug Helps Cut Intake 66% in Clinical Trials
Bloomberg
Monday, March 5, 2012 - 11:07am
tags:
Lundbeck, binge drinking, nalmefene
The Secret Reason Eli Lilly's Earnings Are Awesome
Motley Fool
Monday, March 5, 2012 - 11:06am
tags:
Eli Lilly, earnings
Merck: FDA won't OK its combo cholesterol drug now
Yahoo/AP
Monday, March 5, 2012 - 11:05am
tags:
FDA, Merck, Pfizer, Zetia
Abbott Laboratories' Share Price: Slightly Overvalued
Seeking Alpha
Monday, March 5, 2012 - 11:04am
tags:
Abbott Laboratories
Daiichi Sankyo, GlaxoSmithKline Form Vaccine Venture
WSJ Online
Monday, March 5, 2012 - 11:03am
tags:
GSK, vaccines, Daiichi Sankyo, Japan
Zogenix: Smart Biotech Buy Before Earnings
Seeking Alpha
Monday, March 5, 2012 - 11:02am
tags:
earnings, migraines, Zogenix, Sumavel DosePro, DosePro, Relday, Zohydro
India's Lupin gets US nod for schizophrenia capsules
Reuters
Monday, March 5, 2012 - 11:01am
tags:
India, Lupin, schizophrenia, Geodon, generics
Johnson & Johnson Could Double In 5 Years
Seeking Alpha
Sunday, March 4, 2012 - 12:19pm
tags:
JNJ
NY A.G. Announces $28 Mln In Settlements With Dava Pharma And KV Pharma
RTT News
Sunday, March 4, 2012 - 12:16pm
tags:
KV Pharmaceutical, Dava Pharmaceuticals, settlements, legal
Roche Scores Important Win With Actemra
Seeking Alpha
Sunday, March 4, 2012 - 12:12pm
tags:
Roche, Actemra, arthritis, rheumatoid arthritis
Abbott developing quicker test for orthopedic infections
Reuters
Sunday, March 4, 2012 - 12:10pm
tags:
Abbott Laboratories, PLEX-ID
Merck says pill tames allergic response to ragweed
Reuters
Sunday, March 4, 2012 - 12:02pm
tags:
MK-3641, Merck, ALK-Abello
4 Biotech Stocks Trading At A Steep Discount To Target Price
Seeking Alpha
Sunday, March 4, 2012 - 11:58am
tags:
OncoGenex, Corcept Therapeutics, Curis, Questcor Pharmaceuticals
Actos Bladder Cancer Lawsuits to See First Hearing, Kershaw, Cutter & Ratinoff Reports
Health Care Global
Saturday, March 3, 2012 - 12:33pm
tags:
Actos, bladder cancer, Takeda, lawsuits
Baxter Presents Long-Term Data on HyQ During AAAAI Annual Meeting
PharmPro
Saturday, March 3, 2012 - 12:27pm
tags:
Baxter International, HyQ, immunodeficiency

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.